The maker of Maalox, Novartis Consumer Health, halted manufacture of the product as a pre-emptive action to ensure the product is of the highest quality standards, according to the product’s website, Maalox.com. Production suspension was a voluntary action, and the product is unavailable until further notice as of May 2015.
Novartis Consumer Health’s Lincoln facility no longer produces Maalox, notes the product's website. The company failed to issue a statement regarding the reason behind the production stoppage in its site disclaimer but states that it is working hard to resume producing the medication. It offers no time frame for production to resume. Maalox urges customers with concerns about the availability status of Maalox to contact its customer service line at 800-452-0051.